Cardiovascular Safety of Denosumab Across Multiple Indications-Reference-Cited by-同舟云学术

Cardiovascular Safety of Denosumab Across Multiple Indications

Published:2020-10-23 Issue:3 Volume:36 Page:617-618
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Shao Long¹^ORCID,Wu Xiang‐Dong²^ORCID,Huang Wei³^ORCID

Affiliation:

1. Department of Orthopaedic Surgery Ningbo No.6 Hospital Ningbo China

2. Department of Orthopaedic Surgery, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

3. Department of Orthopaedic Surgery The First Affiliated Hospital of Chongqing Medical University Chongqing China

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4189

Reference5 articles.

1. Cardiovascular safety of denosumab across multiple indications: a systematic review and meta‐analysis of randomized trials;Seeto AH;J Bone Miner Res.,2020

2. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study

3. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

4. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility;Women's Health;2023-01

2. Response to Shao Et Al.;Journal of Bone and Mineral Research;2020-12-13